Beam Therapeutics Inc. (BEAM) Analyst Estimates Annual - Discounting Cash Flows
BEAM
Beam Therapeutics Inc.
BEAM (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-30
2021
12-30
2020
12-30
Number of Analysts 4 9 11 10 10 10 5 3 4 4
Estimated Revenue
Low 150 122.9 21.27 27.29 31.56 43.05 130.4 27.53 5.89 0.005
Average 405.7 126.6 57.5 41.09 36.02 51.41 352.6 54.19 11.6 0.01
High 887.8 130.3 125.8 80.93 45.2 70.96 771.6 105.2 22.52 0.019
Estimated EBITDA
Low -779.3 -114.4 -110.5 -71.04 -39.68 -62.29 -677.3 -324 -746.4 -0.017
Average -356.1 -111.1 -50.48 -36.07 -31.62 -45.13 -309.5 -270 -622 -0.009
High -131.7 -107.9 -18.67 -23.96 -27.7 -37.79 -114.5 -216 -497.6 -0.004
Estimated EBIT
Low -793.2 -116.4 -112.4 -72.3 -40.38 -63.4 -689.4 -407.8 -799.2 -0.017
Average -362.4 -113.1 -51.38 -36.71 -32.18 -45.94 -315 -339.8 -666 -0.009
High -134.1 -109.8 -19 -24.39 -28.2 -38.46 -116.5 -271.9 -532.8 -0.005
Estimated Net Income
Low -619.9 -567.4 -621.2 -504.6 -354.6 -395.8 -369.9 -357.9 -758.1 -534.2
Average -243.6 -523.1 -536 -493.3 -341 -381.8 -143 -298.2 -631.8 -240.1
High -44.04 -177.4 -276.4 -292.9 -327.4 -367.9 -26.28 -238.6 -505.4 -86.53
Estimated SGA Expenses
Low 37,154 30,436 5,267 6,759 7,815 10,661 32,291 6,816 1,459 1.26
Average 100,453 31,351 14,239 10,175 8,919 12,732 87,306 13,419 2,872 2.48
High 219,847 32,266 31,163 20,040 11,193 17,572 191,074 26,060 5,577 4.81
Estimated EPS
Low -7.53 -6.89 -7.55 -6.13 -4.31 -4.81 -4.49 -10.53 -12.69 -6.49
Average -2.96 -4.3 -4.76 -4.67 -4.19 -4.68 -1.77 -4.73 -5.7 -2.92
High -0.535 -2.15 -3.36 -3.56 -3.98 -4.47 -0.319 -1.71 -2.05 -1.05
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program